Cover Image
市場調查報告書

Arno Therapeutics, Inc. - 產品平台分析

Arno Therapeutics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251743
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
Arno Therapeutics, Inc. - 產品平台分析 Arno Therapeutics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 41 Pages
簡介

Arno Therapeutics, Inc. 是總公司設立於美國的製藥企業,正在從事各種癌症治療藥之開發。該公司的產品平台有適用於乳癌及前列腺癌症的Onapristone,骨髓惡性腫瘤,固態腫瘤治療藥物AR-42,及固態腫瘤及淋巴瘤的適應的AR-12等。

本報告提供Arno Therapeutics, Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

目錄

Arno Therapeutics, Inc. 的基本資料

  • Arno Therapeutics, Inc. 概要
  • 主要資訊
  • 企業資料

Arno Therapeutics, Inc. :R&D概要

  • 主要的治療範圍

Arno Therapeutics, Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Arno Therapeutics, Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式
    • 第Ⅰ階段的產品/聯合治療模式
    • 第0相的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Arno Therapeutics, Inc. :藥物簡介

  • onapristone ER
  • AR-42
  • AR-12

Arno Therapeutics, Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Arno Therapeutics, Inc. :最新的開發平台資訊

Arno Therapeutics, Inc. :開發暫停中的計劃

Arno Therapeutics, Inc. :開發中止的開發中產品

Arno Therapeutics, Inc. :企業理念

Arno Therapeutics, Inc. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07391CDB

Summary

Global Markets Direct's, 'Arno Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Arno Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arno Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Arno Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Arno Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Arno Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Arno Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Arno Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Arno Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Arno Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arno Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Arno Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Arno Therapeutics, Inc. Snapshot
    • Arno Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Arno Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Arno Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Arno Therapeutics, Inc. - Pipeline Products Glance
    • Arno Therapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
      • Phase 0 Products/Combination Treatment Modalities
    • Arno Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Arno Therapeutics, Inc. - Drug Profiles
    • onapristone ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-42
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-12
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Arno Therapeutics, Inc. - Pipeline Analysis
    • Arno Therapeutics, Inc. - Pipeline Products by Target
    • Arno Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Arno Therapeutics, Inc. - Pipeline Products by Molecule Type
    • Arno Therapeutics, Inc. - Pipeline Products by Mechanism of Action
  • Arno Therapeutics, Inc. - Recent Pipeline Updates
  • Arno Therapeutics, Inc. - Dormant Projects
  • Arno Therapeutics, Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • AR-67
  • Arno Therapeutics, Inc. - Company Statement
  • Arno Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Arno Therapeutics, Inc., Key Information
  • Arno Therapeutics, Inc., Key Facts
  • Arno Therapeutics, Inc. - Pipeline by Indication, 2015
  • Arno Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Arno Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Arno Therapeutics, Inc. - Phase II, 2015
  • Arno Therapeutics, Inc. - Phase I, 2015
  • Arno Therapeutics, Inc. - Phase 0, 2015
  • Arno Therapeutics, Inc. - Preclinical, 2015
  • Arno Therapeutics, Inc. - Pipeline by Target, 2015
  • Arno Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Arno Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Arno Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Arno Therapeutics, Inc. - Recent Pipeline Updates, 2015
  • Arno Therapeutics, Inc. - Dormant Developmental Projects,2015
  • Arno Therapeutics, Inc. - Discontinued Pipeline Products, 2015

List of Figures

  • Arno Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Arno Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Arno Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Arno Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
  • Arno Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Arno Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Arno Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top